Efficacy and safety of atorvastatin in hyperlipidemic, type 2 diabetic patients. A 34-week, multicenter, open-label study

Carlos A. Aguilar‐Salinas, Francisco J. Gómez‐Pérez, Carlos Posadas‐Romero, C Vázquez-Chávez, Eduardo Meaney, Alfonso Gulı́as-Herrero, Luz E. Guillén, Alma Alvarado Vega, Enrique Mendoza Pérez, Luis Eduardo Romero-Nava,

Atherosclerosis · 2000 · 25 citations · 25 references

Concepts

References

25